Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice.
about
Muscle plasticity and β₂-adrenergic receptors: adaptive responses of β₂-adrenergic receptor expression to muscle hypertrophy and atrophyAnabolic effects of a non-myotoxic dose of the beta2-adrenergic receptor agonist clenbuterol on rat plantaris muscleChanges in skeletal muscle gene expression following clenbuterol administration.Non-invasive muscle contraction assay to study rodent models of sarcopenia.Respiratory muscle fibres: specialisation and plasticity.Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain TransitionThe administration of Fructus Schisandrae attenuates dexamethasone-induced muscle atrophy in miceA novel method to measure glucose uptake and myosin heavy chain isoform expression of single fibers from rat skeletal muscle.Redox homeostasis, oxidative stress and disuse muscle atrophy.Steroid myopathy: some unresolved issues.Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.Impact of diaphragm muscle fiber atrophy on neuromotor control.Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice.The effect of a low dose of clenbuterol on rat soleus muscle submitted to joint immobilization.Extracellular polysaccharides purified from Aureobasidium pullulans SM‑2001 (Polycan) inhibit dexamethasone‑induced muscle atrophy in mice.High-intensity resistance training attenuates dexamethasone-induced muscle atrophy.Daily brief restraint stress alters signaling pathways and induces atrophy and apoptosis in rat skeletal muscle.
P2860
Q27016049-52E5E9E9-E065-414B-9432-230752F4C996Q28566103-F160A387-C8D2-4604-AADF-7487246250EFQ33267204-4BF41B11-A29E-4BE2-8F19-47CAD5A795F9Q34060732-52E476CD-6210-40E3-B7A5-4E0ACFD16463Q35536966-E562C87C-AB11-4812-8E30-E3F3075E2C94Q35656679-C8C631C2-488D-4A6B-A8FF-24B10FFF488FQ35827590-5C46170D-9915-4032-9789-B8D6CAE8E692Q35902929-329D9640-43F4-4FE0-8C4F-21B73BC69BE3Q37841944-E2C91B4E-B0D0-4EB8-A27D-6D546C6CC2E9Q37890215-B691BA66-5011-4FDB-9F2E-CA773E8B3013Q38015162-E8F7098C-7455-4CCD-B2DB-C86CD4A46950Q38119766-CA927857-A147-4D55-A26F-AFCB5370CA0DQ44291723-EDCE0308-F03B-4511-9BFF-79B5E606A0FFQ46160488-7589E88E-411D-4B46-B6CA-150F136A94FEQ47401468-E1F6EFF4-E6C2-4818-83EB-82EFB1C4DCDEQ53350297-6422720C-2F45-4C75-B189-C752D16C5E85Q54708404-4322095B-1421-4776-80EA-A946A2D86710
P2860
Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Clenbuterol antagonizes glucoc ...... e type transformation in mice.
@en
Clenbuterol antagonizes glucoc ...... e type transformation in mice.
@nl
type
label
Clenbuterol antagonizes glucoc ...... e type transformation in mice.
@en
Clenbuterol antagonizes glucoc ...... e type transformation in mice.
@nl
prefLabel
Clenbuterol antagonizes glucoc ...... e type transformation in mice.
@en
Clenbuterol antagonizes glucoc ...... e type transformation in mice.
@nl
P2093
P2860
P1476
Clenbuterol antagonizes glucoc ...... re type transformation in mice
@en
P2093
Biagio Polla
Carlo Reggiani
Federica Boschi
Maria Antonietta Pellegrino
Roberto Bottinelli
Susan Bortolotto
P2860
P304
P356
10.1113/EXPPHYSIOL.2003.002609
P577
2004-01-01T00:00:00Z